Literature DB >> 3377927

Unpredictability of regression of analgesia during the continuous postoperative extradural infusion of bupivacaine.

T Mogensen1, N C Hjortsø, D Bigler, C Lund, H Kehlet.   

Abstract

Twenty-four otherwise healthy patients scheduled for elective major abdominal surgery received general anaesthesia plus lumbar extradural analgesia. A loading dose of 0.5% plain bupivacaine was given to produce sensory analgesia (pin prick) from T4 to S5 and followed by a continuous infusion of 0.5% plain bupivacaine 8 ml h-1. Pain, scored on a 5-point scale, and sensory analgesia were assessed hourly for 16 h after skin incision. If sensory analgesia decreased by more than 5 segments from its preoperative level, or if the pain score reached 2 (moderate pain), the patients were removed from the study, and pain was treated otherwise. Only three patients maintained their initial levels of sensory analgesia and a pain score of less than 2. In the remaining patients sensory analgesia decreased at least 5 segments or pain score reached 2 between 4 and 16 h after skin incision. We found a weak correlation between increasing age and the duration of sensory analgesia (r = 0.46, P less than 0.05), but no significant correlations between duration of sensory analgesia and sex, weight, height, body surface area, serum albumin concentration, duration or site of operation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3377927     DOI: 10.1093/bja/60.5.515

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  2 in total

1.  Risk factors for labor epidural conversion failure requiring general anesthesia for cesarean delivery.

Authors:  Shannon M Grap; Gaurav R Patel; Jessica Huang; Sonia J Vaida
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2021-10-13

2.  The Analgesic Efficiency of Ultrasound-Guided Rectus Sheath Analgesia Compared with Low Thoracic Epidural Analgesia After Elective Abdominal Surgery with a Midline Incision: A Prospective Randomized Controlled Trial.

Authors:  Hany Mahmoud Yassin; Ahmed Tohamy Abd Elmoneim; Hatem El Moutaz
Journal:  Anesth Pain Med       Date:  2017-06-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.